RetatrutideRetatrutide
At a glance
An investigational peptide studied for obesity and type 2 diabetes. It activates three hormone receptors (GLP-1, GIP and glucagon) to reduce appetite, improve blood-sugar control and raise energy expenditure.
Retatrutide is an investigational peptide-based medication being studied primarily for obesity and type 2 diabetes. It works by activating three hormone receptors — GLP-1, GIP, and glucagon receptors — which can reduce appetite and food intake, improve blood-sugar regulation, and increase energy expenditure. Clinical trials have shown substantial reductions in body weight, with improvements also observed in measures such as waist circumference and several metabolic health markers. Its triple-action mechanism is designed to target multiple pathways involved in appetite, metabolism, and energy balance, making retatrutide a promising treatment currently being investigated for weight management and metabolic health. For research use only. Not for human consumption.
Choose a size
Order this product
Message us on WhatsApp at 07361 793324 or email rawpeptides@outlook.com with the product name and quantity. We'll confirm payment and delivery by reply.
Add a starter pack to any order for £10. Just mention it in your message.
Sold for research use only. Not for human consumption. Not for veterinary use.
Product details
Purity
99%+
Size
10mg
Form
Lyophilised Powder
Testing
Certificate below
Certificate of Analysis · 10mg · Batch LU-RT-062610
99.93% purity · Freedom Diagnostics (USA) · June 2026
Certificate of Analysis · 20mg · Batch OP-RT20-0726
99.88% purity · Freedom Diagnostics (USA) · July 2026
Certificate of Analysis · 30mg · Batch V260427-18 008
>99.80% purity · Vanguard Laboratory (ISO 17025 accredited) · May 2026
- Over 99% purity
- Sealed research vial
- Boxed with blister pack
- Store between 2°C and 8°C

